Dear colleagues!
In connection with the tightening of control over the spread of coronavirus infection, the Decree of the Moscow Mayor “On Amendments to the Decree of the Moscow Mayor of March 5, 2020 No. 12-UM” introduced a temporary ban from March 16 to April 10, 2020 for any events with more than 50 people at a time.
In connection with the above the IX International forum for cardiology and internal medicine, scheduled for March 25-27, 2020, is cancelled.
Additional changes and the postponement of the Forum to a later period will be reported.
The abstract book of the Forum will be available on official website www.cardioprogress.ru.
Organizing Committee
ACC Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19)
The bulletin provides background on the epidemic, which was first reported in late December 2019, and looks at early cardiac implications from case reports.
Eating An Egg A Day Is A-OK, Despite Heart Disease History, New Study Suggests
Interest in high-protein and high-fat diets like the keto diet keeps growing, but concerns about the health effects of many foods on those diets remain high. For at least one of those foods—the simple protein-packed egg—a new, large-scale study suggests that devouring one a day is fine for most people, even those with a history of heart disease.
Marijuana may cause the same cardiovascular damage as cigarettes
More than two million Americans with heart disease are using or have used marijuana - and it could put them at risk of dangerously heavy bleeding and other complications, a new study warns.
Don't Stop the Statin! Christopher P. Cannon
Lipid lowering with statins is one of the most beneficial therapies in cardiovascular medicine, with evidence from hundreds of randomized clinical trials, including >25 large cardiovascular outcomes trials in the Cholesterol Treatment Trialists (CTT) collaboration.
Expert point of view
Strategies to Overcome Residual Risk During Statins Era
PreHT 2020|Vilnius | Lithuania | 2-5 April 2020
7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease (PreHT 2020)
FDA Clears Architect Stat High-Sensitivity Troponin Test for MI
The US Food and Drug Administration (FDA) has approved the Architect Stat (Abbott Laboratories) high-sensitivity troponin-I assay, which can detect myocardial infarction (MI) faster and more accurately than other troponin tests, according to the company.
World Heart Day 2019
This year on World Heart Day, as part of our mission to ensure heart health equity for all, we want to create a global community of Heart Heroes … people from all walks of life who are acting now to live longer, better, heart-healthy lives by making a promise: for MY HEART, for YOUR HEART, for ALL OUR HEARTS.
RU
EN
